Alnylam Pharmaceuticals
ALNY
#689
Rank
NZ$64.65 B
Marketcap
NZ$484.29
Share price
-1.64%
Change (1 day)
-6.77%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company